SmarterDx is a company.
SmarterDx has raised $50.0M across 1 funding round.
Key people at SmarterDx.
SmarterDx has raised $50.0M in total across 1 funding round.
SmarterDx has raised $50.0M in total across 1 funding round.
SmarterDx's investors include SignalFire, Transformation Capital.
Key people at SmarterDx.
SmarterDx is a clinical AI company that builds proprietary AI tools to help hospitals analyze 100% of patient charts, capture missed revenue from incomplete documentation, automate denial appeals, and improve care quality metrics.[1][2][3] Serving over 60 health systems and 250+ hospital sites across the U.S., it solves the problem of hospitals leaving millions on the table due to documentation gaps—delivering an average $2-2.5M in net new revenue per 10,000 discharges with a guaranteed 5:1 ROI, while reducing administrative burdens on clinicians.[1][3][5] In 2025, the company was acquired by New Mountain Capital, launching Smarter Technologies to expand AI-driven revenue cycle efficiency.[2][4]
SmarterDx was founded in 2020 by physician-data scientists Dr. Michael Gao (CEO) and Dr. Joshua Geleris (Chief Product and Data Science Officer), both hospitalists with frontline experience.[2][4][5] Gao, while leading AI initiatives as Medical Director at NewYork-Presbyterian, built a proof-of-concept AI that uncovered millions in missed revenue from documentation issues, sparking the idea: if a top hospital struggled, others must too.[1][5] Geleris joined to co-develop the platform amid the pandemic's challenges, pivoting from concurrent CDI to post-discharge analysis (SmarterPrebill™) based on early customer feedback, which accelerated traction and led to rapid growth and the 2025 acquisition.[4]
SmarterDx rides the AI healthcare revolution, targeting revenue cycle management (RCM) inefficiencies amid rising costs, payer scrutiny, and clinician burnout—trends amplified by post-pandemic margin pressures.[1][5] Its timing aligns with hospitals adopting AI for scalability, as manual CDI teams can't handle 100% chart reviews, while regulations demand precise documentation for reimbursement and quality.[3][6] Market forces like value-based care and denial rates favor it, influencing the ecosystem by setting standards for clinician-AI collaboration, reducing administrative overhead (e.g., smaller CDI teams), and enabling sustainable hospital finances to prioritize patient care.[2][4]
Post-2025 acquisition, SmarterDx (now under Smarter Technologies) will likely expand beyond pre-billing to full RCM orchestration, leveraging New Mountain Capital's resources for national scaling and new AI features like real-time documentation aids.[2][4] Trends in multimodal AI, regulatory tailwinds for AI in billing, and hospital AI mandates will propel growth, potentially transforming it into a category leader. Its physician-led model positions it to evolve influence from revenue recovery to holistic clinical intelligence, bridging care and payment at scale—proving clinicians can rocketship AI solutions that make hospitals thrive.
SmarterDx has raised $50.0M across 1 funding round. Most recently, it raised $50.0M Series B in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2024 | $50.0M Series B | SignalFire, Transformation Capital |
